O'NEKA ELLIS: Open Payments
NPI 1164963815 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 4 payments from 3 companies in 2025. Trend: 2023 $61 · 2024 $637 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $245 |
| AstraZeneca Pharmaceuticals LP | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: BREZTRI, AREXVY, SHINGRIX, COBENFY.
Industry payments across TX — which companies pay providers there.
